Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts

Value-based pharmaceutical contracts (VBPCs) are performance-based reimbursement agreements between health care payers and pharmaceutical manufacturers in which the price, quantity, or nature of reimbursement is tied to value-based outcomes. As value-based payment models have permeated through much...

Descripción completa

Detalles Bibliográficos
Autores principales: Kannarkat, Joseph T., Good, Chester B., Kelly, Erin, Parekh, Natasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
ViewPoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390966/
https://www.ncbi.nlm.nih.gov/pubmed/31880231
http://dx.doi.org/10.18553/jmcp.2020.26.1.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390966/
https://www.ncbi.nlm.nih.gov/pubmed/31880231
http://dx.doi.org/10.18553/jmcp.2020.26.1.63

Ejemplares similares